MIRA Pharmaceuticals Says It Completed Dosing In Exploratory Non-GLP 7-Day Toxicology Studies Of MIRA-55 And SKNY-1, Advancing Both Toward IND-Enabling Development

뉴스 본문을 불러오고 있어요.

MIRA Pharmaceuticals Says It Completed Dosing In Exploratory Non-GLP 7-Day Toxicology Studies Of MIRA-55 And SKNY-1, Advancing Both Toward IND-Enabling Development | 웨이프 WAPE

MIRA Pharmaceuticals Says It Completed Dosing In Exploratory Non-GLP 7-Day Toxicology Studies Of MIRA-55 And SKNY-1, Advancing Both Toward IND-Enabling Development

기사 요약

관련 종목

댓글 —